Akadeum to Present at Biotech Showcase 2025 in San Francisco
Event Start Date: 01/13/2025 Share
Innovation takes center stage on January 13th, 2025, as Dr. Brandon McNaughton, CEO of Akadeum Life Sciences, presents the performance of the Alerion™ Microbubble Cell Separation System at Biotech Showcase 2025 in San Francisco. Designed to address unmet cell therapy market needs of scale, gentleness, speed and performance in cell separation, the Alerion system is redefining what’s possible in research and therapeutic applications. Akadeum’s technology and products have been and are in the process of being selected for process development programs at multiple cell therapy leading companies.
Biotech Showcase, known as the premier event for innovative life science companies, will provide a unique opportunity to demonstrate the award-winning, market-disrupting system to an audience of global investors, biotech executives, and thought leaders.
Presentation details:
- Date: Monday, January 13, 2025
- Time: 10:15 am Pacific
- Location: Hilton Union Station, Franciscan A; San Francisco, CA
Individuals interested in learning more about the Alerion or partnering with Akadeum are encouraged to book a meeting with McNaughton.
About the Alerion™ Microbubble Cell Separation System
The Alerion™ Microbubble Cell Separation System leverages Akadeum’s patented microbubble technology to offer unmatched purity, viability and yield in isolating target cells in a fraction of the time of magnetic methods. Engineered to drive processes forward, the system addresses critical challenges faced by researchers and clinicians in achieving consistent, high-quality cell separations that result in healthy cells for downstream therapeutics.
Key benefits of the Alerion include:
- High Purity, Viability, and Yield: More, healthier cells enable better therapeutics.
- Versatility in Scale and Application: Adaptable for use in various applications, with large-scale separation (up to 100 billion cells) now possible for negative selection and depletion
- Efficiency: 5x faster than traditional magnetic methods, minimizing cell handling for better cell outcomes.
Combined with GMP and Clinical Ready microbubble reagents, the Alerion delivers for therapeutic developers from process development through commercialization.
“This technology represents a quantum leap forward in cell separation,” said McNaughton. “We are thrilled to share how the Alerion™ Microbubble Cell Separation System is reshaping cell separation with the biotech community at the Biotech Showcase. It reflects our commitment to enabling innovation in the life sciences and giving researchers the tools to achieve results they never thought possible.”
See you in San Francisco!
For more updates, travel with us by following our LinkedIn page.